Professor Maria Svensson
Uppsala University and Uppsala University Hospital, Uppsala (Sweden)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Low-density lipoprotein cholesterol reduction with evolocumab and its use in clinical practice: evidence from swedish national register data
Event: ESC Congress 2022
Topic: Lipid-Lowering Agents
Session: Lipid-lowering by PCSK9 modulation: what’s new?
A real-world analysis of characteristics and lipid-lowering therapy use in patients initiating treatment with evolocumab in Sweden
Event: ESC Congress 2021 - The Digital Experience
Topic: Drug therapy
Session: Risk Factors and Prevention ePosters
